IBA to install cyclotron in Italy

Installation of an IBA (Ion Beam Applications) cyclotron, beam line and two patient treatment rooms has begun at the Agenzia Provinciale Per la Protonterapie, a cancer center being constructed in Trento, Italy.

IBA engineers expect the proton beam system and first patient treatment room to be ready for commissioning in about one year. Commissioning is a month-long process that includes confirming proton beam uniformity and accuracy, and integrating imaging into the proton targeting system, according to the company. It is the final stage before clinicians at the facility can begin using the proton beams.

The cancer center will house two gantry treatment rooms and a research room. Each of the treatment rooms will be equipped with IBA’s Pencil Beam Scanning nozzle, with a beam spot as fine as 3 mm.

To date, Louvain-la-Neuve, Belgium-based IBA has 12 operational proton therapy centers globally, and nine more centers in development.



Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.